期刊文献+

新型AT_1受体拮抗剂Ⅰb对异丙肾上腺素诱发大鼠心肌肥厚的作用 被引量:2

Effects of a new angiotensin type 1 receptor antagonist Ⅰb on isoproterenol-induced cardiac hypertrophy in rats
下载PDF
导出
摘要 目的:考察AT1受体拮抗剂Ⅰb对异丙肾上腺素诱发大鼠心肌肥厚的作用。方法:异丙肾上腺素连续每日以20,10和5mg/kg的剂量递减皮下注射,再以3mg/kg的剂量维持皮下注射7d,第7天开始尾静脉注射化合物Ⅰb。观察心脏重量系数、心肌组织丙二醛(MDA)含量、心肌组织超氧化物歧化酶(SOD)活力、血清乳酸脱氢酶(LDH)活力以及组织学变化。结果:3mg/kg组可以逆转异丙肾上腺素所致大鼠心肌肥厚,心脏重量系数明显改善,心肌组织MDA含量降低,SOD活力升高,血清LDH活力下降。电镜结果显示心肌组织线粒体和肌纤维结构改善。结论:化合物Ⅰb可抑制异丙肾上腺素引起的大鼠心肌肥厚,明显改善心肌肥厚的各种指征。 Aim: To study the effects of compound Ⅰ b as a new angiotensin type 1 receptor antagonist on isoproterenolinduced cardiac hypertrophy in rats. Methods: Cardiac hypertrophy in rats was induced by subcutaneous administration of isoproterenol in which the dosage schedule was set to 20 mg/kg in the 1st day, 10 mg/kg in the 2nd day, 5 mg/kg in the 3rd day, and 3mg/kg in the following consecutive seven days. Compound Ⅰ b was given to rats via tail vein in the 7th day. Cardiac mass index, malondialdehyde(MDA) content of cardiac muscle, the activity of cardiac muscle superoxide dismutase (SOD)and the lactate dehydrogenase (LDH) released to the serum were observed. Results: It was shown that at a dose of 3mg/kg Ⅰb improved the cardiac mass index, significantly decrease MDA content of the cardiac muscle, increased the activity of cardiac muscle SOD, and significantly decreased the LDH released to the serum. Electron microscope showed that Ib improved the structure of cardiac muscle fiber and mitochondria. Cardiac muscle fiber lined up in order, and Z line was clear. Conclusion: Compound Ⅰ b was shown to be effective against isoproterenol-induced cardiac hypertrophy in rats.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第5期433-436,共4页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.30371688) 教育部重点基金资助项目(No.03089)~~
关键词 化合物Ⅰb 异丙肾上腺素 心肌肥厚 AT1受体桔抗剂 compound Ⅰ b isoproterenol cardiac hypertrophy angiotensin receptor antagonists
  • 相关文献

参考文献10

  • 1Weber KT, Brilla CG. Structural basis for pathologic left ventricular hypertrophy[J]. Clin Cardiol, 1993,16(5): 10 - 14.
  • 2Nishikawa K. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage[J]. J Hum Hypertens, 1998, 12(5) :301 - 309.
  • 3徐进宜,周宇昕,吴晓明,唐康,王秋娟.1-芳基-3-烷基-1,4-二氢-4-取代-5H-1,2,4-三唑啉酮-5衍生物的合成及生物活性[J].中国药科大学学报,1999,30(5):332-337. 被引量:5
  • 4吴锦慧,王秋娟,胡松,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对大鼠的降压作用[J].中国药科大学学报,2005,36(6):563-566. 被引量:7
  • 5张静,王秋娟,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对L-甲状腺素诱发大鼠心肌肥厚的作用[J].中国药科大学学报,2006,37(2):157-160. 被引量:7
  • 6Rona G, Chappel CI, Balazs T, et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat[J]. Arch Pathol, 1959,67(4) :443 - 455.
  • 7Zou Y, Takano H, Akazawa H, et al. Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy[J], Endocr J,2002,49(1) :1 - 13.
  • 8Ocaranza MP, Diaz-Araya G, Chiong M, et al. Isoproterenol and anglotensin I -converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis[J]. J Cardiovasc Pharmacol,2002,40(2) :246 - 254.
  • 9Golomb E, Abassi ZA, Cude G, et al. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats [J].Am J Physiol,1994:267(4):1496-1506.
  • 10Chiu AT,Roscoe WA,McCall DE, et al. AngⅡ-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cell[J]. Receptor, 1991,1(3) : 133 - 140.

二级参考文献15

  • 1傅继华,王秋娟,张陆勇.动物血压的长时间记录及分析处理系统[J].中国药科大学学报,1995,26(4):230-234. 被引量:4
  • 2吴锦慧,王秋娟,胡松,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对大鼠的降压作用[J].中国药科大学学报,2005,36(6):563-566. 被引量:7
  • 3Greathouse M.A review of olmesartan medoxomil monotherapy:antihypertensive efficacy similar to that of other angiotensin Ⅱ receptor blocker/hydrochlorothiazide combinations [J].Congest Heart Fail,2002,8(6) :313 - 320.
  • 4Lee BH,Seo HW,Kwon KJ,et al.In vivo pharmacologic profile of SK-1080,an orally active nonpeptide ATi-receptor antagonist[J].J Cardiovosc Pharmacol,1999,33(3):375-382.
  • 5Bernhart CA,Perreaut PM,Ferrari BP,et al.A new series of imidazolones:highly specific and potent nonpeptide AT1 angiotensin Ⅱ receptor antagonists[J].J Med Chem,1993,36(22) :3 371 -3 380.
  • 6Stekiel TA,Conntney SJ,Kokite N,et al.Mechanisms of isofluranemediated hyperpolarization of vascular smooth muscle in chronically hypertensive and normotensive conditions[J].Anesthesiology,2001,94(3) :496 - 506.
  • 7Weber KT,Brilla CG.Structural basis for pathologic left ventricular hypertrophy[J].Clin Cardiol,1993,16(5):S10-S14.
  • 8Nishikawa K.Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage[J].J Hum Hypertens,1998,12(5):301-309.
  • 9Binah O,Rubinstein I,Gilat E.Effects of thyroid hormone on the action potential and membrane currents of Guinea pig ventricular myocytes[J].Pflugers Arch,1987,409(3):214-216.
  • 10Zou Y,Takano H,Akazawa H,et al.Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy[J].Endocr J,2002,49(1):1-13.

共引文献11

同被引文献15

  • 1周晓莉,雷寒,柳青.血管平滑肌细胞的培养及鉴定[J].重庆医学,2005,34(6):877-878. 被引量:32
  • 2吴锦慧,王秋娟,胡松,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对大鼠的降压作用[J].中国药科大学学报,2005,36(6):563-566. 被引量:7
  • 3张静,王秋娟,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对L-甲状腺素诱发大鼠心肌肥厚的作用[J].中国药科大学学报,2006,37(2):157-160. 被引量:7
  • 4张斐,李小敏,涂秀芹,许向阳,陈峻崧.伏格列波糖中有机溶剂残留量的毛细管GC测定[J].中国医药工业杂志,2006,37(11):773-774. 被引量:2
  • 5王玉,王秋娟,吴锦慧,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对血管紧张素Ⅱ的拮抗作用[J].中国药科大学学报,2007,38(1):69-72. 被引量:3
  • 6Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases [ J ]. Pharmacol Rev,2000,52 ( 1 ) : 11 - 34.
  • 7Moore MA. Choosing initial antihypertensive drug therapy for the uncomplicated hypertensive patient[ J ]. J Clin Hyperten ,2001,3 (1) :37 -44.
  • 8Chanudet X, De Champvallins M. Antihypertensive efficacy and tolerability of low dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension [ J ]. Int J Clin Praet,2001,55 (4) :233 - 239.
  • 9Wang Y, Wang W, Wang Q, et al. [ Ca^2+] i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide angiotensin Ⅱ subtype AT1 receptor antagonist, on angiotensin Ⅱ-induced vascular contraction in vitro [ J ]. Biochem Biophys Res Commun ,2007,364 ( 1 ) : 118 - 123.
  • 10Yan B, Wang G, Sun J, et al. Identification of the major metabolites of 5-n-butyl-4-{ 4-[ 2-( 1H-tetrazole-5-yl ) -1H-pyrrol-1 -yl ] phenylmethyl / -2,4 -dihydro-2 - ( 2,6 -dichloridephenyl ) -3 H-1, 2, 4-triazol-3-one,a new angiotensin type 1 receptor antagonist, in rat bile by HPLC-diode array detection-MS and HPLC-MS/MS [ J ]. Biomed Chromatogr,2007,21 ( 9 ) :912 - 924.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部